Qualitative and quantitative analyses of Epstein-Barr virus early antigen diffuse component by western blotting enzyme-linked immunosorbent assay with a monoclonal antibody. by Lin, Jung-Chung et al.
JOURNAL OF VIROLOGY, Mar. 1985, p. 793-799
0022-538X/85/030793-07$02.00/0
Copyright © 1985, American Society for Microbiology
Qualitative and Quantitative Analyses of Epstein-Barr Virus Early
Antigen Diffuse Component by Western Blotting Enzyme-Linked
Immunosorbent Assay With a Monoclonal Antibody
JUNG-CHUNG LIN,* ETSUYO I. CHOI, AND JOSEPH S. PAGANO
Lineberger Cancer Research Center and Departments of Biochemistry and Nutrition, Medicine, and Microbiology, School
of Medicine, University of North Carolina, Chapel Hill, North Carolina 27514
Received 13 August 1984/Accepted 30 November 1984
We report the use of monoclonal antibody against the early antigen diffuse component (anti-EA-D) of
Epstein-Barr virus (EBV) to analyze, both qualitatively and quantitatively, the expression of EA-D in various
human lymphoblastoid cell lines activated by chemical inducers. The kinetics of synthesis of EA-D in P3HR-1,
B95-8, and Ramos/AW cells were similar in that they all reached the peak of synthesis on day 5 after induction.
Surprisingly, no expression of EA-D was found in induced BJAB/GC, an EBV-genome-containing cell line.
EBV-negative cell lines, BJAB and Ramos, were negative for EA-D. Raji cells had no detectable EA-D but
responded rapidly to induction, reaching a peak on day 3. Superinfection of Raji cells also resulted in marked
induction of EA-D, which reached a plateau between 8 to 12 h postinfection. Western blotting coupled with the
enzyme-linked immunosorbent assay was employed to identify polypeptides representing EA-D. A family of
four polypeptides with molecular weights of 46,000 (46K protein), 49,000, 52,000, and 55,000 were identified
to be reactive with monoclonal anti-EA-D antiserum. The pattern of EA-D polypeptides expressed in each cell
line was different. Of particular interest was the expression of a large quantity of 46K protein both in induced
Raji and P3HR-1 cells, but not in superinfected Raji cells. A 49K doublet was expressed in activated p3HR-1,
B95-8, and Ramos/AW cells and in superinfected Raji cells. In addition, two distinct 52K and 55K polypeptides
were expressed in induced Ramos/AW and superinfected Raji cells. However, none of these EA-D polypeptides
was detectable in BJAB/GC, BJAB, Ramos, and mock-infected Raji cells. To approximate relative concen-
trations of EA-D in cell extracts, we employed the enzyme-linked immunosorbent assay and immunoblot dot
methods by using one of the purified EA-D components to construct a standard curve. Depending upon the cell
lines, it was estimated that ca. 1 to 3% (determined by the enzyme-linked immunosorbent assay) and 0.8 to
1.6% (determined by immunoblot dot) of total proteins from maximally induced cells were EA-D. These results
suggest that differential expression of EA-D polypeptides could be of importance in the diagnosis of state of
EBV infection.
Human lymphoblastoid cell lines carrying latent Epstein-
Barr virus (EBV) genomes vary widely in the expression of
viral antigens and in the production of infectious virus
particles. A number of EBV-associated antigen complexes
have been differentiated by immunofluorescence techniques
(8). These have been designated the EBV-determined nu-
clear antigen (EBNA) (24), the early antigen complex (EA)
(10), the viral capsid antigen (VCA) (7), and the membrane
antigens (15). In virus producer lines, a small proportion of
the cells are continuously activated to enter the lytic cycle
(11). In nonproducer lines, cells do not spontaneously enter
the viral cycle; they carry multiple copies of the EBV
genome (22) and express nuclear antigen (24). Virus activa-
tion in producer cells (P3HR-1) after treatment with 12-0-
tetradecanoyl-phorbol-13-acetate (TPA) results in a dramatic
increase in EBV DNA replication (17-20), paralleling the
appearance of viral antigen synthesis (17), whereas compa-
rable treatment of nonproducer cells (Raji) results in synthe-
sis of only EA (17, 30).
The EA is synthesized early in abortive or permissive
infections, whereas VCA and membrane antigens are late
viral gene products expressed in permissively infected cells.
On the basis of immunofluorescent staining, the EA complex
reveals two distinct patterns: one shows diffuse staining of
the nucleus and cytoplasm in both acetone and methanol-
* Corresponding author.
fixed cells; the other is restricted to the cytoplasm in
acetone-fixed cells and is denatured by methanol (9). Anti-
bodies to EA complex frotm patients with infectious
mononucleosis and nasopharyngeal carcinoma are directed
primarily against the diffuse component, whereas those from
patients with African Burkitt' s lymphoma are directed mainly
against the restricted component (9).
The synthesis of EA in EBV-infected cells could be
important for initiation of viral DNA replication and the
subsequent expression of VCA. Although EA is recognized
to be a complex, little is known about the polypeptides that
compose this antigen. Recently Pearson et al. (23) developed
a monoclonal antibody against the EA diffuse component
(anti-EA-D) which recognizes two polypeptides with molec-
ular weights of 50,000 to 52,000 (50 to 52K polypeptides).
Polypeptides that are in some way involved in DNA repli-
cation or control of gene expression are likely to be associ-
ated in the nucleus (20). Since EA-D is present in the
nucleus, we considered that a comparative analysis of the
expression of this antigen in both producer and nonproducer
cell lines by a well-characterized monoclonal antibody (an-
ti-EA-D) (23) would provide a first step in elucidating the
possible role of EA-D in viral replication. In this report we
analyze, both quantitatively and qualitatively, the EA-D
components in various human lymphoblastoid cell lines
activated by chemical inducers.
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MATERIALS AND METHODS
Cell cultures, The lymphoblastoid cell lines used in these
studies were P3HR-1, Raji, B95-8, BJAB, BJAB/GC, Ramos,
and Ramos/AW. The lines were propagated as suspension
cultures in RPMI 1640 medium, supplemented with 10% fetal
calf serum, streptomycin (100 pug/ml), and penicillin (100
IU/ml) as described elsewhere (17).
Assay of EA-D synthesis in chemically induced cells. Expo-
nentially growing cells were harvested by centrifugation and
incubated in fresh medium containing TPA (30 ng/ml) and 5
mM butyrate. Samples of cells were taken daily, and smears
were prepared on standard painted microscope slides
(Carlson Scientific, Inc.). After drying, the smears were
fixed either by cold (-20°C) acetone for 5 min or by
methanol for 10 min at room temperature (9). Assay of EA-D
was carried out by indirect immunofluorescence method (7)
with a monoclonal anti-EA-D antibody (Biotech Research
Laboratories, Inc.).
Preparation of cell extracts. In parallel with immunofluor-
escent assay for EA-D, samples of chemically induced cell
samples were harvested, washed, and resuspended in cell
lysis buffer containing 50 mM Tris-hydrochloride (pH 7.4),
0.15 M NaCl, 0.5% Triton X-100, 0.5% deoxycholate, and 1
mM phenylmethylsulfonyl fluoride. Cells were disrupted in
an Ultrasonic sonicator three times for 30 s each with a
microtip, followed each time by a 30-s interval of cooling on
ice. Cell extracts were clarified by centrifugation at 10,000
rpm for 20 min in a Sorvall HB-4 rotor.
Sodium dodecyl sulfate-polyacrylamide gel electrophoresis.
The cell extracts were analyzed on 7.5% slab gels by the
method of Laemmli (16). The proteins were treated with
sample buffer, and samples of 100 pul containing 200 pug of
proteins were electrophoresed at 8 mA per slab for 18 h.
Western blot of protein. After electrophoresis, the gel was
immersed in gel washing buffer (10 mM Tris-hydrochloride
[pH 7.0], 50 mM NaCl, 2 mM Na-EDTA, 4M urea, and 0.1
mM dithiothreitol) and gently agitated for 3 h. The transfer
of proteins from gel to nitrocellulose sheets (BA85; Schlei-
cher & Schuell, Inc.) was performed according to the
diffusion method (2). The gel was sandwiched between two
sheets of nitrocellulose and pressed together by two sheets
of foam pad in a "sandwich" apparatus. The apparatus was
submerged in a solution of transfer buffer (10 mM Tris-hy-
drochloride [pH 7.0], 50 mM NaCl, 2 mM Na-EDTA, and
0.1 mM dithiothreitol) for 48 h at room temperature. The
initial solution was replaced after 16 h with fresh buffer.
Detection of EA-D components. The advantage of the
diffusion method is two identical sheets with mirror images
of polypeptide patterns obtained after transfer. One sheet
can be reacted with human EA+-VCA+ antiserum to detect
the general pattern of EBV-associated polypeptides; the
other sheet can be reacted with monoclonal anti-EA-D to
identify the polypeptides representing EA-D.
The nitrocellulose sheets were saturated with protein by
incubating for 1 h at 37°C in blocking solution containig
phosphate-buffered saline solution (PBS) (pH 7.4), 3% bo-
vine serum albumin (BSA), and 10% heat-inactivated calf
serum. The sheets were then incubated for 1 h at 37°C with
monoclonal anti-EA-D or human EA+-VCA+ serum, fol-
lowed by washing in PBS four times for 15 min each. The
final incubations were for 2 h at room temperature in rabbit
anti-mouse (or anti-human) immunoglobulin G conjugated
with peroxidase (Miles Laboratories, Inc.). After the sheets
were again washed as above, antigenic bands were stained in
4-chloro-1-naphthol (60 mg in 20 ml of ice-cold methanol),
0.005% H202, and 100 ml TBS buffer (20 mM Tris-hydro-
chloride [pH 7.5], 0.5 M NaCi). Unless otherwise stated, all
the antisera were diluted in blocking solution.
Quantitation of EA-D. (i) Imtnunoblot dot. The nitrocellu-
lose sheet was soaked in TBS buffer and assembled into the
Bio-Dot microfiltration apparatus (Bio-Rad Laboratories).
The proteins were directly spotted on the nitrocellulose
sheets. The sheets were soaked in blocking solution, fol-
lowed by incubation with monoclonal anti-EA-D, and proc-
essed as above for immunoperoxidase staining. After color
development, the sheet was washed in distilled water and air
dried overnight on a Whatman filter paper in the dark at
room temperature. The intensity of each spot was scanned
by using Bio-Rad model 1650 Transmittance/Reflectance
Scanning Densitometer in the reflectance mode. The scan
was recorded, and the peak height or peak area was meas-
ured for quantitation. One of the EA-D components (the 49K
protein) purified by preparative gel electrophoresis (J.-C.
Lin, unpublished data) was used to construct a standard
curve.
(ii) ELISA. The assays were carried out essentially as
described elsewhere (3) in a 96-well microtitrator plate
(Linbo/Titertek; Flow Laboratories, Inc.). Duplicate sam-
ples (20 jig/ml) of serial dilutions were assayed by adding 50
,ul per well in 0.05 M carbonate buffer (pH 9.6), which was
allowed to absorb overnight at 4°C. The excess antigen was
then aspirated off, and 150 RI per well of 5% BSA in PBS was
added to block the unreacted sites on the solid phase. After
3 h at 37°C, the BSA solution was removed, and 50 RI of
monoclonal anti-EA-D of appropriate dilution (diluted in
PBS-BT [PBS containing 0.5M NaCl, 2% BSA, and 0.05%
Tween 20]) was added to each well and incubated at room
temperature for 45 min. The plates were washed three times
for 5 min each with PBS containing 0.05% Tween 20. To
each well 50 pI of alkaline phosphatase-conjugated goat
antibody to mouse immunoglobulin (Miles Laboratories)
was added and incubated for 45 min at room temperature.
The plates were then washed as above, and 100 pI of 10%
diethanolamine buffer (pH 9.8) containing 0.5 mM MgCl2
and 0.1% of 4-nitrophenyl phosphate was added to each
well. After 30 min at room temperature, the reaction was
stopped by adding 25 ,u of 2 N NaOH. The activity was
determined by measuring the A450 on a Microelisa Auto
Reader, model MR580 (Dynatech Laboratories).
RESULTS
Kinetics of induction of EA-D expression. The kinetics of
EA-D synthesis in various lymphoblastoid cell lines after
chemical induction are shown in Fig. 1. The kinetics of
synthesis of EA-D in two virus producer cell lines, P3HR-I
and B95-8, and in one EBV-converted subline, Ramos/AW,
are similar in that they all reach the peak of synthesis on day
5 after induction (Fig. 1A and B). Surprisingly, no expres-
sion of EA.D was found in another EBV-converted subline,
BJAB/GC, even after treatment with inducers (Fig. 1A).
This is in contrast to Ramos/AW, which expresses high level
of EA-D even before induction. The EBV-negative lines
BJAB and Ramos, however, did not synthesize EA-D. In
nonproducer Raji cells the expression of EA-D was unde-
tectable but responded rapidly to chemical induction, reach-
ing a peak on day 3 (Fig. 1C). Superinfection of Raji cells
also resulted in marked induction of EA-D synthesis, which
reached a plateau between 8 to 12 h postinfection and was
maintained at this high level (ca. 55% of the cells were
positive for EA-D) up to 24 h.
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Identification of EA-D complexes in activated P3HR-1 cells.
To identify and characterize the polypeptides that react with
monoclonal anti-EA-D antibody, we employed the Western
blotting-ELISA technique. Figure 2 shows the polypeptides
from induced P3HR-1 cells reacted with monoclonal anti-
EA-D antibody. The uninduced P3HR-1 cells expressed
predominantly a 49K polypeptide doublet and a minor 46K
polypeptide (Fig. 2, panel I). Upon exposure of the cells to
inducers, synthesis of the 49K protein increased with the
time of induction and reached its maximum on day 3,
gradually decreasing thereafter. In contrast, the maximum
synthesis of the 46K protein was on day 5. To correlate these
induced EA-D components with EBV-associated polypep-
tides, cell lysates prepared from superinfected and mock-in-
fected Raji cells were analyzed in adjacent slots of the same
gel (designated as S and M). It appears that superinfected
Raji cells synthesized a larger quantity of the 49K polypep-
tide and a small amount of the 46 K polypeptide (Fig. 2,
panel I, slot S). In addition, two 52K and 55K polypeptides
were expressed in superinfected Raji cells but not in induced
p3HR-1 cells. However, none of these polypeptides was
detectable in mock-infected Raji cells.
To cross-identify EA-D components wtih those of EBV-
associated polypeptides, the second nitrocellulose sheet,
which is the mirror image of the first sheet used to detect
EA-D, was reacted with human EA+-VCA+ antiserum,
followed by incubation with peroxidase-conjugated anti-hu-
man immunoglobulin G antibodies. At least 25 EBV-associ-
ated polypeptides with molecular masses between 18,000
and 200,000 daltons were found to react specifically with this
human serum (Fig. 2, panel II). Identical protein-banding
patterns that represent EA-D components between molecu-
lar weights of 46,000 and 55,000 were observed with both
human serum and monoclonal antibody.
Polypeptide of EA-D complexes from activated B95-8 and
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FIG. 2. Identification of EA-D polypeptides in activated P3HR-1
cells. EA-D polypeptides were identified by the Western-blotting-
ELISA technique, which involves reaction of the monoclonal anti-
body with cell lysates subjected to electrophoresis in sodium
dodecyl sulfate-polyacrylamide gels and then transferred to nitro-
cellulose sheets as detailed in the text. Panel I, Reactions with
monoclonal anti-EA-D monoclonal antibody; panel II, reaction with
human EA+-VCA+ serum. The numbers at the head of the lanes
represent days after induction. Lanes S and M, Superinfected and
mock-infected Raji cells, respectively. The numbers with arrows
indicate molecular masses (x 103 daltons).
shown in Fig. 3, panel I. Before induction B95-8 cells
expressed a small amount of 49K polypeptide. Upon expo-
sure of cells to inducers, synthesis of the 49K polypeptide
increased with the time of induction with the simultaneous
synthesis of two additional 46K and 55K polypeptides. The
52K polypeptide either formed a diffuse band or was lacking
in B95-8 cells.
Synthesis of EA-D components in Raji cells was negligible
before induction (Fig. 3, panel II). Upon exposure of cells to
inducers for 1 day, synthesis of the 49K polypeptide was
markedly induced. Concurrent with the maximum induction
I











FIG. 1. Kinetics of induction of EA-D expression. Indirect im-
munofluorescence staining with a monoclonal anti-EA-D antibody
was performed as described in the text.
FIG. 3. Polypeptides of EA-D complexes from activated B95-8
and Raji cells. The same methods as described in the legend to Fig.
2 were employed to identify the EA-D polypeptides.
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FIG. 4. Differential expression of EA-D complexes in EBV-converted cell lines. Panel I, Staining for EA-D; panel II, staining for EBNA.
of the 49K polypeptide on day 3 was the appearance of the
46K and 55K polypeptides. A diffuse, not well-resolved 52K
polypeptide was discernible. Synthesis of the 46K polypep-
tide gradually decreased after day S in contrast to the rapid
decrease of the 55K polypeptide after day 3. Therefore, the
polypeptide patterns were essentially similar in the two cell
lines.
Differential expression of EA-D complexes in EBV-con-
verted cell lines. Two EBV-converted B-cell lines, BJAB/GC
and Ramos/AW, were used for this study. Figure 4 shows
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FIG. 5. Quantitation of EA-D by ELISA. Panel A, A purified
EA-D component (the 49K polypeptide) was used as antigen; panel
B, induced Raji cell extract as antigen. Symbols: A, EA-D antigen
reacted with monoclonal anti-EA-D antibody; 0, EA-D antigen
reacted with control serum; 0, mock preparation of antigen from
BJAB reacted with monoclonal anti-EA-D antibody.
did not express any EA-D components even after induction.
Furthermore, in agreement with the immunofluorescent data
(Fig. 1A), no EA-D components were detectable in BJAB/GC
cells before and after induction. This is in contrast to
Ramos/AW cells, which synthesized a large quantity of 49K
and 55K polypeptides before induction. On day 3 after
induction, a diffuse 46K band was detectable. On day 5, an
additional 52K band was induced.
The failure to detect any EA-D component in BJAB/GC
cells could result from an artifact due to mistaking BJAB for
BJAB/GC during sample loading. Since the presence or
absence of EBV DNA and EBNA is the only known
difference between the BJAB and BJAB/GC cell lines, we
determined whether the BJAB/GC cell line expresses EBNA.
The second nitrocellulose sheet (Fig. 4, panel II) of the
mirror image of the first sheet (Fig. 4, panel I) was stained
for EBNA after reaction with EBNA+ human serum (1:640).
It is clearly shown in Fig. 4 (panel II) that both Ramos/AW
and BJAB/GC cells expressed EBNA with molecular weights
of 72,000 and 80,000, respectively.
Titration of EA-D by ELISA. To assess the sensitivity and
specificity of ELISA for detecting EA-D, dilutions of puri-
fied EA-D preparations were used. EA-D was readily de-
tected at concentrations as low as 80 ng/ml (E450 = 0.4) when
reacting with monoclonal anti-EA-D antibody (Fig. 5A).
There was no significant reaction with control serum (mouse
ascites fluids) nor with a mock preparation of EA-D.
Estimation of EA-D content was made by using cell
extracts from different cell lines. A typical result is illus-
trated in Fig. 5B with Raji cells. EA-D was detected in
extracts from induced Raji cells at very high dilutions (low
antigenic concentrations), whereas a similarly treated ex-
tract from uninduced Raji cells gave no detectable reaction.
The activity increased with the increasing concentrations of
the antigen coated on the wells. Activity curves similar to
those shown in Fig. 5B were observed with cell extracts
from induced P3HR-1, B95-8, and Ramos/AW cells. Based
on the antigenic concentration required to reach the same
level of activity as in the purified EA-D standard assay (Fig.
5A), it was estimated that ca. 1 to 3% of the total protein
from the maximally induced cells was EA-D.
Quantitation of EA-D by immunoblot dot. Experiments
were performed to determine whether immunoblot dots for
EA-D could be used quantitatively. First, duplicate samples
of 12 dilutions of purified EA-D from induced Raji cells were
tested. A positive concentration-dependent response was
observed with monoclonal anti-EA-D antiserum (Fig. 6A)
but not with control serum (Fig. 6B). As little as 1.25 ng of
EA-D could be detected by this method. Densitometric
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Relative concentration of EA-D in cell extracts. To approx-
imate concentrations of immunoreactive EA-D in different
cell lines, cell extracts prepared from induced and uninduced
cells were measured by immunoblot dots by using a cali-
brated EA-D standard curve (Fig. 6A). By comparing the
intensity of dots obtained from each cell line (Fig. 7) with
that of standard curve, the relative concentration of EA-D in
each cell extract was determined. Approximately 0.8 to
1.6% of total protein in induced cell extracts was EA-D.
Table 1 summarizes the quantitative data obtained by EL-
ISA and immunoblot dot. The results obtained by both
methods are comparable.
DISCUSSION
In the past few years several attempts were made to
identify EA complex (1, 5, 6, 13, 14, 21). These reports
involved using mixtures of EA+-VCA+ human sera to
immunoprecipitate the presumptive early polypeptides asso-
ciated with viral infection or chemical induction. Since
immunoreagent monospecific for EA was not available, the
results reported by these authors varied. Thus, it has not
been possible conclusively to associate a specific polypep-
tide component with the antigens detected by immunofluo-
rescent method. There has been considerable progress in
recent years, however, in the identification of polypeptides
representing EA, VCA, and membrane antigens because of
the availability of the monoclonal antibodies (4, 23, 27, 28).
Two monoclonal antibodies against EA-D were independent-
ly developed by Pearson (23) and Epstein (4). The antibody
(R3) of Pearson recognizes two major 50K and 52K polype-
ptides, whereas the antibodies (1108-1 and 1129-1) of Epstein
react with the 50K and 55K polypeptides. Electrophoretic
transfer of protein from polyacrylamide gel into nitrocellu-
lose membrane (Western blot) (29) has become a powerful
tool in protein immunochemical research. Using the mono-
clonal antibody of Pearson in the Western-blotting-ELISA
method, we were able to identify unequivocally a family of
four polypeptides with molecular weights of 46,000, 49,000,
52,000, and 55,000 are major components of EA-D. Differ-
ential expression of each component of EA-D was observed
among different cell lines. For instance, P3HR-1 cells ex-
press only the 46K and 49K polypeptides, whereas superin-
fected Raji cells synthesize the whole spectrum of EA-D
components, the 46K, 49K, 52K, and 55K polypeptides. In
contrast, after chemical induction, both B95-8 and Raji cells
express the 46K, 49K, and 55K polypeptides, but the 52K
polypeptide was not well resolved. The doublet of the 49K
polypeptide is expressed in all EBV-genome positive cell
lines (P3HR-1, B95-8, superinfected Raji, chemically in-
duced Raji, and Ramos/AW) except BJAB/GC. This polype-
ptide seems to be conserved in all different states of EBV
infection, and its expression is inducible. The patterns of
EA-D expression in induced Raji and B95-8 cells are similar,
but different from that of P3HR-1 cells in which the 52K and
55K polypeptides are lacking. The molecular basis for this
difference is not known.
The concern that the increase in the 46K protein could be
due to the proteolytic degradation of the 49K protein is very
unlikely since, as observed both in Raji and B95-8 cells, the
increase in the 46 K polypeptide is accompanied by an
increase in a new higher-molecular-weight 55K polypeptide
without simultaneous decrease in the 49K polypeptide.
The present results do not permit us to deduce the
relationship between the 46K protein and the in vitro trans-
lation product, the 47K polypeptide, identified by Pearson et
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FIG. 6. Quantitation of EA-D by immunoblot dot. A purified
EA-D component (the 49K polypeptide) was applied to a sheet of
nitrocellulose membrane in the Bio-Dot apparatus. (A) Reacts with
monoclonal anti-EA-D antibody; (B) reacts with control serum. The
following amounts of antigen in TBS buffer were applied: 160 ng
(row 1), 140 ng (row 2), 120 ng (row 3), 100 ng (row 4), 80 ng (row 5),
40 ng (row 6), 20 ng (row 7), 10 ng (row 8), 5 ng (row 9), 2.5 ng (row
10), 1.25 ng (row 11), and 0.625 ng (row 12). The total sample
volume for each well was 400,ul. Excess sites on the membrane
were saturated by blocking solution. The antigenic sites were
revealed by the immunoperoxidase staining technique as described
in the text.
translation products, the 44 to 47K polypeptides identified
by Pearson et al. (23), and the in vitro intracellular 46 to 55K
proteins identified by us with the same monoclonal antibody
suggests that post-translational modification is involved in in
vivo situations.
Of particular interest is the expression of the whole
spectrum of EA-D component in Ramos/AW cells, but none
of them in BJAB/GC cells (Fig. 4). This result is in agree-
ment with the immunofluorescent data (Fig.1A). Expression
of EA-D polypeptides in Ramos/AW cells, but not in
BJAB/GC cells, is surprising since both EBV-converted cell
lines contain viral DNA and express EBNA (Fig. 5). Whether
this is due to a lack of or defect in BJAB/GC of the
VOL. 53, 1985 797
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FIG. 7. Quantitation of EA-D complexes from various cell lines. Cell extracts were applied to a sheet of nitrocellulose membrane. The
following amounts of antigen in TBS buffer were applied: 10 p.g (row 1), 8 ,ug (row 2), 6 ,ug (row 3), 4 ,ug (row 4), 2 ,ug (row 5), 1 ,ug (row 6),
0.5,ug (row 7), 0.25 ,ug (row 8), 0.125 ,ug (row 9), 0.0625 ,ug (row 10), and 0.03125 ,ug (row 11). Row 12 contained 1% BSA in TBS buffer and
was used as a blank. Od, 3d, and Sd represent the duration (days) of induction.
BamHI-M fragment, which has been mapped to code for
EA-D (23), remains to be examined.
It has been shown that EA-D is encoded by the BamHI-M
fragment, which encodes 4.0-, 2.65-, and 1.9-kilodalton early
RNAs (12). Variable initiation or termination of a single
RNA could result in differential expression of polypeptides
with different molecular weights. The fact that anti-EA-D
antibody recognizes a common determinant present on the
46K, 49K, 52K, and 55K polypeptides may indicate that
these proteins are likely translated from the same nucleotide
sequence in the identical reading frame.
With a purified EA-D component (the 49K polypeptide) as
a standard antigen, we were able to estimate the relative
concentrations of EA-D in various cell lines (Table 1). The
present results indicate that the EA-D components can be
detected qualitatively by Western-blotting-ELISA and quan-
titatively both by ELISA and immunoblot dot methods.
These results, as far as we are aware, represent the first
report demonstrating the differential expression, both qual-
itatively and quantitatively, of EBV-associated EA-D com-
TABLE 1. Induction of expression of EA-D in various cell lines'











" All cell lines were induced by TPA and butyrate except SI Raji, which
were Raji cells superinfected by EBV derived from P3HR-1 cells.
b Quantitation was done with cell extracts from maximally induced cul-
tures.
ponents in different cell lines. The assays developed here are
potentially useful in handling large-scale seroepidemiologic
studies in EBV-related diseases.
We have recently shown that activation of latent EBV
genomes by TPA is accompanied by the selective stimula-
tion of synthesis of six EBV-associated chromosomal pro-
teins with molecular weights of 145,000, 140,000, 135,000,
110,000, 85,000, and 55,000 (20). It appears that the 55K
polypeptide is one of the EA-D components. Studies on
DNA-binding properties of EA polypeptides indicated that
the 50 to 55K polypeptides have significant DNA-binding
activity (25, 26). The nuclear location of the EA-D polypep-
tides suggests that EA-D might be involved in an early stage
of viral gene expression.
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